Literature DB >> 24318915

Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastoma.

Davis C Woodworth1, Whitney B Pope, Linda M Liau, Hyun J Kim, Albert Lai, Phioanh L Nghiemphu, Timothy F Cloughesy, Benjamin M Ellingson.   

Abstract

The purpose of this study was to use a retrospective nonlinear distortion correction technique and evaluate the changes in DTI metrics in areas of interest in and around GBM tumors. A total of 24 histologically confirmed GBM patients with pre-operative 20-direction DTI scans were examined. Variability in apparent diffusion coefficient (ADC) and fractional anisotropy (FA) in normal tissue before and after distortion correction were examined. Changes in mean, median and variance of ADC and FA in contrast enhancing and T2/FLAIR ROIs were also examined with and without distortion correction. Results suggest the intra-subject SDs of ADC and FA decreased in normal tissue after the application of distortion correction (P < 0.0001). FA mean and median values decreased after distortion correction in both T1+C and T2 ROIs (P < 0.017), while ADC mean and median values did not significantly change except for the median ADC in T1+C ROIs (P = 0.0054). The intra-subject SD of ADC and FA values in tumor ROIs changed significantly with distortion correction, and Bland-Altman analysis indicated that the bias and the SD of the bias of these intra-subject SDs were larger than those of the mean and median terms. Additionally, the means of the two curves of a double Gaussian fit to the histogram of ADC values from T1+C ROIs, ADCL (mean of lower Gaussian) as well as ADCH (mean of the higher Gaussian) were found to change significantly with distortion correction (P = 0.0045 for ADCL and P = 0.0370 for ADCH). Nonlinear distortion correction better aligns neuro-anatomical structures between DTI and anatomical scans, and significantly alters the measurement of values within tumor ROIs for GBM patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24318915      PMCID: PMC3918907          DOI: 10.1007/s11060-013-1320-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

Review 1.  Sources of distortion in functional MRI data.

Authors:  P Jezzard; S Clare
Journal:  Hum Brain Mapp       Date:  1999       Impact factor: 5.038

2.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.

Authors:  Y Zhang; M Brady; S Smith
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

3.  Characterization and propagation of uncertainty in diffusion-weighted MR imaging.

Authors:  T E J Behrens; M W Woolrich; M Jenkinson; H Johansen-Berg; R G Nunes; S Clare; P M Matthews; J M Brady; S M Smith
Journal:  Magn Reson Med       Date:  2003-11       Impact factor: 4.668

4.  Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

5.  Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma.

Authors:  R K Gupta; T F Cloughesy; U Sinha; J Garakian; J Lazareff; G Rubino; L Rubino; D P Becker; H V Vinters; J R Alger
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

6.  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.

Authors:  T L Chenevert; L D Stegman; J M Taylor; P L Robertson; H S Greenberg; A Rehemtulla; B D Ross
Journal:  J Natl Cancer Inst       Date:  2000-12-20       Impact factor: 13.506

7.  Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging.

Authors:  H Lyng; O Haraldseth; E K Rofstad
Journal:  Magn Reson Med       Date:  2000-06       Impact factor: 4.668

8.  Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma.

Authors:  R K Gupta; U Sinha; T F Cloughesy; J R Alger
Journal:  Magn Reson Med       Date:  1999-01       Impact factor: 4.668

Review 9.  Cost of migration: invasion of malignant gliomas and implications for treatment.

Authors:  A Giese; R Bjerkvig; M E Berens; M Westphal
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

10.  Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion?

Authors:  S J Price; N G Burnet; T Donovan; H A L Green; A Peña; N M Antoun; J D Pickard; T A Carpenter; J H Gillard
Journal:  Clin Radiol       Date:  2003-06       Impact factor: 2.350

View more
  8 in total

1.  Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden.

Authors:  Kunal S Patel; Richard G Everson; Jingwen Yao; Catalina Raymond; Jodi Goldman; Jacob Schlossman; Joseph Tsung; Caleb Tan; Whitney B Pope; Matthew S Ji; Nhung T Nguyen; Albert Lai; Phioanh L Nghiemphu; Linda M Liau; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  Neurosurgery       Date:  2020-10-15       Impact factor: 4.654

2.  Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials.

Authors:  Benjamin M Ellingson; Elizabeth R Gerstner; Marion Smits; Raymond Y Huang; Rivka Colen; Lauren E Abrey; Dana T Aftab; Gisela M Schwab; Colin Hessel; Robert J Harris; Ararat Chakhoyan; Renske Gahrmann; Whitney B Pope; Kevin Leu; Catalina Raymond; Davis C Woodworth; John de Groot; Patrick Y Wen; Tracy T Batchelor; Martin J van den Bent; Timothy F Cloughesy
Journal:  Clin Cancer Res       Date:  2017-06-27       Impact factor: 12.531

3.  Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma.

Authors:  Benjamin M Ellingson; Eunhee Kim; Davis C Woodworth; Helga Marques; Jerrold L Boxerman; Yair Safriel; Robert C McKinstry; Felix Bokstein; Rajan Jain; T Linda Chi; A Gregory Sorensen; Mark R Gilbert; Daniel P Barboriak
Journal:  Int J Oncol       Date:  2015-02-11       Impact factor: 5.650

4.  Global diffusion tensor imaging derived metrics differentiate glioblastoma multiforme vs. normal brains by using discriminant analysis: introduction of a novel whole-brain approach.

Authors:  Ernesto Roldan-Valadez; Camilo Rios; David Cortez-Conradis; Rafael Favila; Sergio Moreno-Jimenez
Journal:  Radiol Oncol       Date:  2014-04-25       Impact factor: 2.991

5.  Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma.

Authors:  Kunal S Patel; Jingwen Yao; Catalina Raymond; William Yong; Richard Everson; Linda M Liau; David Nathanson; Harley Kornblum; Chencai Wang; Talia Oughourlian; Albert Lai; Phioanh L Nghiemphu; Whitney B Pope; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  Sci Rep       Date:  2020-09-09       Impact factor: 4.379

6.  Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma.

Authors:  Benjamin M Ellingson; Kunal Patel; Chencai Wang; Catalina Raymond; Andrew Brenner; John F de Groot; Nicholas A Butowski; Leor Zach; Jian L Campian; Jacob Schlossman; Shan Rizvi; Yael C Cohen; Noa Lowenton-Spier; Tamar Rachmilewitz Minei; Shifra Fain Shmueli; Patrick Y Wen; Timothy F Cloughesy
Journal:  Neurooncol Adv       Date:  2021-06-19

7.  The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model.

Authors:  Celina Garcia; Luiz Gustavo Dubois; Anna Lenice Xavier; Luiz Henrique Geraldo; Anna Carolina Carvalho da Fonseca; Ana Helena Correia; Fernanda Meirelles; Grasiella Ventura; Luciana Romão; Nathalie Henriques Silva Canedo; Jorge Marcondes de Souza; João Ricardo Lacerda de Menezes; Vivaldo Moura-Neto; Fernanda Tovar-Moll; Flavia Regina Souza Lima
Journal:  BMC Cancer       Date:  2014-12-08       Impact factor: 4.430

8.  Diffusion Tensor Imaging in Patients with Glioblastoma Multiforme Using the Supertoroidal Model.

Authors:  Choukri Mekkaoui; Philippe Metellus; William J Kostis; Roberto Martuzzi; Fabricio R Pereira; Jean-Paul Beregi; Timothy G Reese; Todd R Constable; Marcel P Jackowski
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.